Document Detail

Norplant in South Africa--the first 100 patients.
MedLine Citation:
PMID:  9180818     Owner:  NLM     Status:  MEDLINE    
High maternal mortality rates coupled with poor socioeconomic conditions in developing countries indicate the need for those truly dedicated to improvement of maternal well-being to investigate advances in methods of pregnancy regulation and to implement those found to be effective and acceptable. In a trial involving 100 patients at Tygerberg Hospital that commenced in December 1993, Norplant was found to be highly acceptable and easy to use. It is strongly recommended that the acceptability of Norplant to the general South African population be evaluated further and then, hopefully, made available to all our people without undue delay.
P C Duminy
Related Documents :
10959448 - Emergency contraception.
9220228 - Return of fertility after discontinuation of the once-a-month injectable contraceptive ...
3071108 - Fifteen years' experience with the multiload iud.
9989008 - Norplant utilization in a latina inner-city population.
4022518 - Plasmapheresis for the treatment of repeated early pregnancy wastage associated with an...
24741608 - The many faces of human leukocyte antigen-g: relevance to the fate of pregnancy.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde     Volume:  87     ISSN:  0256-9574     ISO Abbreviation:  S. Afr. Med. J.     Publication Date:  1997 Feb 
Date Detail:
Created Date:  1997-07-08     Completed Date:  1997-07-08     Revised Date:  2014-09-12    
Medline Journal Info:
Nlm Unique ID:  0404520     Medline TA:  S Afr Med J     Country:  SOUTH AFRICA    
Other Details:
Languages:  eng     Pagination:  226-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Contraceptive Agents, Female / adverse effects,  therapeutic use*
Drug Implants / adverse effects,  therapeutic use
Levonorgestrel / adverse effects,  therapeutic use*
Progesterone Congeners / adverse effects,  therapeutic use*
South Africa
Reg. No./Substance:
0/Contraceptive Agents, Female; 0/Drug Implants; 0/Progesterone Congeners; 5W7SIA7YZW/Levonorgestrel

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The prevalence of domiciliary deliveries in Khayelitsha, Cape Town.
Next Document:  Abnormal eating attitudes in secondary-school girls in South Africa--a preliminary study.